Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is an effective and safe treatment for alopecia areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib effectively treats Alopecia Areata.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

This therapy effectively treats resistant alopecia areata with minimal side effects.

COVID-19 doesn't make alopecia areata worse.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.